Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
TELO.Vthis companyTelo Genomics Corp.	CA$0.05	-1.74×	-2.54×	0×	-2.44×	-121.0%	0.0%	0.0%	0.0%	146.0%	1560.7%	-40.1%	-0.91×	-0.53×	-11.44×	0.21×	0.0%	1	-90.75	2	C
AVCR.VAvricore Health Inc.	CA$0.05	-2.72×	13×	9.49×	-3.94×	-985.8%	44.3%	-256.1%	-348.2%	-477.1%	-351.0%	-17.9%	0×	0.19×	-151.48×	2.11×	0.0%	2	-12.33	1	D+
KNE.VKane Biotech Inc.	CA$0.03	-2.38×	-8.69×	15.17×	-2.68×	-157.1%	-38.2%	-727.4%	-636.0%	364.5%	-192.2%	-50.2%	-3.09×	-0.48×	-12.82×	0.68×	0.0%	3	-28.19	2	C
MUSH.VMercanto Holdings Inc.	CA$0.10	-10×	16.94×	1.37×	-9.49×	-4527.7%	20.8%	-13.7%	-13.8%	-170.4%	-170.2%	5.1%	0×	1.01×	-435.35×	1.29×	0.0%	4	-5.11	1	C-
RVV.CNRevive Therapeutics Ltd.	CA$0.02	-12.5×	-3.24×	0×	-12.34×	-98.9%	0.0%	0.0%	0.0%	25.5%	26.8%	-1.2%	0×	0.01×	-91.54×	0.04×	0.0%	3	-414.75	2	C
TGIF.CN1933 Industries Inc.	CA$0.01	-25×	-1.07×	0.28×	21.83×	-4744.4%	29.6%	3.9%	-1.2%	4.7%	-11.2%	34.0%	-3.83×	16.96×	1.02×	0.84×	0.0%	5	-7.98	2	C
Peer median	—	-10×	-1.07×	1.37×	-3.94×	-985.8%	20.8%	-13.7%	-13.8%	4.7%	-170.2%	-1.2%	0×	0.19×	-91.54×	0.84×	0.0%	3	-12.33	2	—